73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Circular RNAs—the new frontier in cancer research

Circular RNAs—the new frontier in cancer research

byFlinders UniversityCircular RNA biogenesis and how they are dysregulated in cancer. Credit:Nature Reviews Cancer(2024). DOI: 10.1038/s41568-024-00721-7Unraveling the complexities o

Circular RNAs—the new frontier in cancer research

byFlinders UniversityCircular RNA biogenesis and how they are dysregulated in cancer. Credit:Nature Reviews Cancer(2024). DOI: 10.1038/s41568-024-00721-7Unraveling the complexities o
Research tests cost-effective approach to early-cancer detection from cell-free DNA in blood samples

Research tests cost-effective approach to early-cancer detection from cell-free DNA in blood samples

byUniversity of California, Los AngelesCredit: Pixabay/CC0 Public DomainEarly detection remains key to successfully treating many cancers, and early detection via cell-free DNA (cfDNA) circulati

Research tests cost-effective approach to early-cancer detection from cell-free DNA in blood samples

byUniversity of California, Los AngelesCredit: Pixabay/CC0 Public DomainEarly detection remains key to successfully treating many cancers, and early detection via cell-free DNA (cfDNA) circulati
Drug combination shows promise in preclinical models of triple negative breast cancer

Drug combination shows promise in preclinical models of triple negative breast cancer

by Alhaji Janneh,Medical University of South CarolinaYueying Liu and Dr. Antonio Giordano study PLK1 inhibitors, traffic light-like signals that stop the uncontrolled growth of breast cancer cel

Drug combination shows promise in preclinical models of triple negative breast cancer

by Alhaji Janneh,Medical University of South CarolinaYueying Liu and Dr. Antonio Giordano study PLK1 inhibitors, traffic light-like signals that stop the uncontrolled growth of breast cancer cel
Study: More aggressive treatments needed to improve 5-year survival rate for glioblastoma

Study: More aggressive treatments needed to improve 5-year survival rate for glioblastoma

by Joe Dangor,Mayo ClinicCredit: Mayo ClinicDespite improvements in median and short-term survival rates for patients with glioblastoma, the most common brain tumor in adults, the percentage of

Study: More aggressive treatments needed to improve 5-year survival rate for glioblastoma

by Joe Dangor,Mayo ClinicCredit: Mayo ClinicDespite improvements in median and short-term survival rates for patients with glioblastoma, the most common brain tumor in adults, the percentage of
New drugs are improving survival times for patients with aggressive type of blood cancer, study finds

New drugs are improving survival times for patients with aggressive type of blood cancer, study finds

by BloodwiseCredit: Wikimedia CommonsSurvival times for a highly aggressive type of blood cancer have nearly doubled over the last decade due to the introduction of new targeted drugs, a Yorkshire stu

New drugs are improving survival times for patients with aggressive type of blood cancer, study finds

by BloodwiseCredit: Wikimedia CommonsSurvival times for a highly aggressive type of blood cancer have nearly doubled over the last decade due to the introduction of new targeted drugs, a Yorkshire stu
Cancer of the appendix: Very rare, but genes may play role

Cancer of the appendix: Very rare, but genes may play role

by Cara MurezWhile appendix cancer is rare, for a small percentage of patients the disease may be linked to a particular genetic variant, a new study suggests.Researchers built on earlier research wit

Cancer of the appendix: Very rare, but genes may play role

by Cara MurezWhile appendix cancer is rare, for a small percentage of patients the disease may be linked to a particular genetic variant, a new study suggests.Researchers built on earlier research wit
Discovery boosts the potential of new cancer-fighting drugs

Discovery boosts the potential of new cancer-fighting drugs

by The Scripps Research InstituteCancer cell during cell division. Credit: National Institutes of HealthScientists at Scripps Research have uncovered a critical feature that a promising new class

Discovery boosts the potential of new cancer-fighting drugs

by The Scripps Research InstituteCancer cell during cell division. Credit: National Institutes of HealthScientists at Scripps Research have uncovered a critical feature that a promising new class
Researchers identify possible role of Foxp1 protein in control of autoimmune diseases

Researchers identify possible role of Foxp1 protein in control of autoimmune diseases

by National Research University Higher School of EconomicsCredit: CC0 Public DomainScientists at the Higher School of Economics, the Institute of Bioorganic Chemistry of the Russian Academy of Science

Researchers identify possible role of Foxp1 protein in control of autoimmune diseases

by National Research University Higher School of EconomicsCredit: CC0 Public DomainScientists at the Higher School of Economics, the Institute of Bioorganic Chemistry of the Russian Academy of Science
Enhanced treatment of liver carcinoma with a drug-eluting hydrogel

Enhanced treatment of liver carcinoma with a drug-eluting hydrogel

by Stewart Han, Terasaki Institute for Biomedical InnovationScientists from the Terasaki Institute for Biomedical Innovation (TIBI) have developed an injectable or catheter-administered hydrogel with

Enhanced treatment of liver carcinoma with a drug-eluting hydrogel

by Stewart Han, Terasaki Institute for Biomedical InnovationScientists from the Terasaki Institute for Biomedical Innovation (TIBI) have developed an injectable or catheter-administered hydrogel with
Exploring ways to overcome cisplatin resistance and alleviate pain in cancer treatment

Exploring ways to overcome cisplatin resistance and alleviate pain in cancer treatment

by Korea University College of MedicineThe study reveals that the transcription factor NANOG activates the transient receptor potential vanilloid 1 (TRPV1)—causing neuropathic pain. TRPV1 further stim

Exploring ways to overcome cisplatin resistance and alleviate pain in cancer treatment

by Korea University College of MedicineThe study reveals that the transcription factor NANOG activates the transient receptor potential vanilloid 1 (TRPV1)—causing neuropathic pain. TRPV1 further stim
Unique insights into differences between primary and metastatic cancer by large-scale DNA data analyses

Unique insights into differences between primary and metastatic cancer by large-scale DNA data analyses

by Hartwig Medical FoundationInference of HLA-I tumor status with LILAC. a, Representation of the six immune escape pathways considered in the present study alongside their associated genes (adapted f

Unique insights into differences between primary and metastatic cancer by large-scale DNA data analyses

by Hartwig Medical FoundationInference of HLA-I tumor status with LILAC. a, Representation of the six immune escape pathways considered in the present study alongside their associated genes (adapted f
Using mice with humanized immune systems to test cancer immunotherapies

Using mice with humanized immune systems to test cancer immunotherapies

byKobe UniversityCurrently developed cancer immunotherapies modify the interaction of cancer cells and the immune system, making drug testing targeting human cancer outside of clinical trials di

Using mice with humanized immune systems to test cancer immunotherapies

byKobe UniversityCurrently developed cancer immunotherapies modify the interaction of cancer cells and the immune system, making drug testing targeting human cancer outside of clinical trials di